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Effectiveness of strategies to improve health-care provider 
practices in low-income and middle-income countries: 
a systematic review
Alexander K Rowe, Samantha Y Rowe, David H Peters, Kathleen A Holloway*, John Chalker, Dennis Ross-Degnan
Summary
Background Inadequate health-care provider performance is a major challenge to the delivery of high-quality health 
care in low-income and middle-income countries (LMICs). The Health Care Provider Performance Review (HCPPR) 
is a comprehensive systematic review of strategies to improve health-care provider performance in LMICs.
Methods For this systematic review we searched 52 electronic databases for published studies and 58 document 
inventories for unpublished studies from the 1960s to 2016. Eligible study designs were controlled trials and 
interrupted time series. We only included strategy-versus-control group comparisons. We present results of improving 
health-care provider practice outcomes expressed as percentages (eg, percentage of patients treated correctly) or as 
continuous measures (eg, number of medicines prescribed per patient). Effect sizes were calculated as absolute 
percentage-point changes. The summary measure for each comparison was the median effect size (MES) for all 
primary outcomes. Strategy effectiveness was described with weighted medians of MES. This study is registered with 
PROSPERO, number CRD42016046154.
Findings We screened 216 477 citations and selected 670 reports from 337 studies of 118 strategies. Most strategies had 
multiple intervention components. For professional health-care providers (generally, facility-based health workers), the 
effects were near zero for only implementing a technology-based strategy (median MES 1·0 percentage points, 
IQR –2·8 to 9·9) or only providing printed information for health-care providers (1·4 percentage points, –4·8 to 6·2). 
For percentage outcomes, training or supervision alone typically had moderate effects (10·3–15·9 percentage points), 
whereas combining training and supervision had somewhat larger effects than use of either strategy alone 
(18·0–18·8 percentage points). Group problem solving alone showed large improvements in percentage outcomes 
(28·0–37·5 percentage points), but, when the strategy definition was broadened to include group problem solving 
alone or other strategy components, moderate effects were more typical (12·1 percentage points). Several multifaceted 
strategies had large effects, but multifaceted strategies were not always more effective than simpler ones. For lay 
health-care providers (generally, community health workers), the effect of training alone was small (2·4 percentage 
points). Strategies with larger effect sizes included community support plus health-care provider training 
(8·2–125·0 percentage points). Contextual and methodological heterogeneity made comparisons difficult, and most 
strategies had low quality evidence.
Interpretation The impact of strategies to improve health-care provider practices varied substantially, although 
some approaches were more consistently effective than others. The breadth of the HCPPR makes its results 
valuable to decision makers for informing the selection of strategies to improve health-care provider practices in 
LMICs. These results also emphasise the need for researchers to use better methods to study the effectiveness of 
interventions.
Funding Bill & Melinda Gates Foundation, CDC Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Health-care providers, including facility-based and 
community-based health workers, are essential for 
delivering high-quality health care. However, hundreds 
of studies have documented inadequate health-care 
provider performance in low-income and middle-income 
countries (LMICs).1–9
Numerous strategies to improve health-care provider 
performance have been tested in LMICs, and a summary 
of the evidence about successful approaches would be 
valuable for decision makers. Many systematic reviews 
have been done for specific sets of strategies or types of 
health services,6,10–19 but a common shortcoming of these 
studies is that they include only a limited range of 
strategies for improving health-care provider perform ance 
in LMICs. To answer the broad programmatic question 
about the most effective ways to improve health-care 
provider performance, all strategies would need to be 
compared. The Health Care Provider Performance Review 
(HCPPR) is designed to help fill this gap. The primary 
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objective of the HCPPR is to assess the effectiveness 
and cost of all strategies to improve health-care provider 
performance outcomes in LMICs. Strategies in the 
HCPPR include components directly targeting individual 
health-care provider behaviour (eg, training and super-
vision) as well as broader, systems-level interventions 
to reform or strengthen areas such as health system 
financing, management, and infrastructure.
Health worker performance is a relatively broad 
construct that encompasses availability, clinical compe-
tence, responsiveness (providing patient-centred care), 
and productivity (or efficiency).20 Studies in the HCPPR 
use a multitude of outcomes that reflect health-care 
provider practices, patients’ health outcomes, and other 
aspects of performance. Here, we present results of 
the effectiveness of strategies to improve health-care 
provider practices expressed as percentages (eg, per-
centage of patients diagnosed or treated correctly) or as 
continuous measures (eg, number of medicines pre-
scribed per patient). Improving health-care provider 
practices is important for programmes and the patients 
they serve, as well as being relevant for meeting the UN 
Sustainable Development Goal of achieving universal 
health coverage.1 Improvements in health-care provider 
practices have been found to be highly correlated with 
improvements in patients’ health outcomes.21 This 
outcome category also had the largest number of studies 
in the HCPPR.
Methods 
Search strategy and selection criteria
The HCPPR is a systematic review that includes all 
elements recommended by the PRISMA guidelines.22 
The PRISMA checklist and the review protocol are in 
appendix 1 (pp 2–25).
We included published and unpublished studies from 
LMICs that quantitatively evaluated strategies to improve 
health-care provider performance (for detailed inclusion 
criteria see appendix 1, pp 8–10). Eligible strategies had to 
include at least one intervention component that could 
plausibly affect performance. Health-care providers were 
broadly defined as hospital-based, clinic-based, or 
community-based health workers; pharmacists and 
dispensers; and shopkeepers and informal vendors who 
sell medicines. Studies could include multiple health-
care provider types and multiple service delivery settings 
(eg, hospital inpatient wards and hospital-based 
outpatient clinics). Eligible study designs comprised pre-
intervention versus post-intervention studies with a 
randomised or non-randomised comparison group, post-
intervention only studies with a randomised comparison 
group, and interrupted time series (ITS) with at least 
three baseline and follow-up measures. We included 
studies on any health condition, in any language, and 
from public and private sector settings. We only included 
results for primary study outcomes. For this report, we 
only included health-care provider practice outcomes, 
Research in context
Evidence before this study
We did not do a systematic review to establish the need for the 
Health Care Provider Performance Review (HCPPR). Before the 
HCPPR protocol was developed in 2005, we examined 
three landmark reviews of the effectiveness of multiple strategies 
to improve health-care provider performance and found 
important limitations. One study was not a systematic review, and 
it included studies from both high-income countries (HICs) and 
low-income and middle-income countries (LMICs). A second 
study was a systematic review, but the literature search from 1998 
was outdated, and nearly all studies were from HICs. A third study 
was a systematic review of studies from LMICs, but the literature 
search from 1999 was outdated, and the review only included 
studies on improving antimicrobial use, which excluded many 
important aspects of health care. We also identified nine reviews 
of individual strategies. Although these reviews were important 
contributions to the literature, their shared limitation was that 
they each only evaluated a single strategy; and, taken together, 
they only covered a relatively narrow set of strategies.
Added value of this study
The evidence about the effectiveness of all strategies to improve 
health-care provider practices in LMICs (evaluated with 
reasonably good quality studies, and acknowledging that some 
studies were inevitably missed, which is a limitation of all 
reviews) has been, to the best of our knowledge, summarised for 
the first time with a single analytical approach in one systematic 
review. The public release of the review’s database will allow 
others to do analyses that are tailored to the needs of specific 
health programmes (eg, for a particular geographical location, 
health condition, or health-care delivery setting).
Implications of all the available evidence
Results of the HCPPR support 14 guidance statements on 
improving health-care provider practices in LMICs. For example, 
the review identified strategies that tended to have large effect 
sizes (eg, group problem solving plus training), which 
programmes might consider using, as well as strategies that 
were generally ineffective (eg, only providing printed 
information to health-care providers), which health 
programmes might want to avoid. The review also found wide 
variability in the effects of nearly all strategies tested by multiple 
studies, which underscores the importance of monitoring the 
effect of any strategy. Future research should identify the 
attributes of commonly used strategies, such as training and 
supervision, that are associated with effectiveness; focus on a 
better understanding of how context influences strategy 
effectiveness; emphasise the use of robust and standardised 
methods; and include more rigorous studies of strategies to 
improve the performance of community health workers.
See Online for appendix 1
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which are health-care provider behaviours such as patient 
assessment, diagnosis, and treatment (full list provided 
in appendix 1, pp 83, 84). This report only includes 
strategy-versus-control group comparisons (head-to-head 
comparisons will be analysed separately). A comparison 
denotes an examination or analysis of two study groups 
(or a study group and its historical control in ITS studies). 
A study (eg, with three groups) could have several 
comparisons. For percentage outcomes, we excluded 
effect sizes with baselines of 95% or greater, as there was 
little room for improvement.
We searched 52 electronic databases for published 
studies and 58 document inventories for unpublished 
studies from the 1960s to 2016. Literature searches were 
done from 2006 to 2008 (Rowe SY, unpublished) and 
from October, 2015, to May, 2016 (appendix 1, pp 26–37). 
We also screened personal libraries, asked colleagues for 
unpublished studies, and hand-searched bibliographies 
from previous reviews.
Titles and abstracts were screened to identify relevant 
reports. If this screening was insufficient for establishing 
eligibility, the report’s full text was reviewed. Data were 
abstracted independently by two investigators or research 
assistants by use of a standardised form. Discrepancies 
were resolved through discussion. Data were entered into 
a computer database (Microsoft Access, Microsoft Inc, 
Professional Plus 2016). Data elements included study 
setting and timing, health-care provider type, improvement 
strategies, study design, sample size, outcomes, effect 
sizes, risk of bias domains, and economic evaluations. 
Study investigators were queried about details not available 
in the study reports.
Time trends in study attributes
We defined the time for a given study as the publication 
year. If study results were presented in multiple reports, 
we analysed the year that the first report identified 
by the HCPPR was publicly available. Time trends for 
dichotomous study attributes were assessed by logistic 
regression. Time trends in the number of studies per year 
were assessed with a Poisson regression model, or with a 
negative binomial regression model to address over-
dispersion. Goodness-of-fit was assessed with a χ² test of 
deviance, with a p value greater than 0·05 indicating 
adequate model fit. For analyses of the number of studies 
per year, studies published after 2015 were excluded as 
such studies did not represent all research done after that 
time because of the literature search end date of May, 2016.
Definition of strategy groups
To define mutually exclusive strategy groups, we coded 
the presence of 207 strategy components for each study 
group exposed to an improvement strategy and grouped 
them into 13 component categories (panel 1; appendix 1, 
pp 39–44). A unique strategy was any unique combi-
nation of the 13 component categories. Placebo strategy 
com ponents were analysed with control groups, which 
received no new intervention. After ascertaining that 
there was no meaningful difference between results of 
low-intensity and high-intensity training (appendix 1, 
pp 88, 93), these results were combined into a single “any 
training” category.
Assessment of risk of bias, quality of evidence, and 
publication bias
Our study-level risk of bias assessment was based on 
guidance from the Cochrane Effective Practice and 
Organisation of Care Group;23 the categories were low, 
moderate, high, and very high (appendix 1, pp 45–47). 
Our strategy-level quality of evidence (QOE) assessment 
used the Grading of Recommendations Assessment, 
Development, and Evaluation (GRADE) system 
(appendix 1, pp 48–51),24 which has four categories: high, 
moderate, low, and very low. To identify publication bias, 
we examined funnel plots and did Egger’s test for 
strategies tested by at least ten comparisons.25
Estimation of effect sizes
The primary outcome measure was the effect size, 
which was defined as an absolute percentage-point 
difference and calculated such that positive values 
indicate improvement. For study outcomes that 
decreased to indicate improvement (eg, percentage of 
patients receiving unnecessary treatments), we 
multiplied effect sizes by –1. Effect sizes for percentage 
and continuous outcomes were calculated differently 
(see below) and analysed separately.
For non-ITS studies, effect sizes were based on the 
baseline value closest in time to the beginning of the 
strategy and the follow-up value furthest in time from 
the beginning of the strategy. In non-ITS studies, for 
outcomes that were dichotomous, percentages, or 
bounded continuous outcomes that could be converted 
to percentages (eg, performance score ranging 
from 0 to 12), the effect size was calculated with 
equation 1:
In non-ITS studies, for unbounded continuous 
outcomes, the effect size was calculated with equation 2. 
If the baseline value for either the intervention or control 
group equalled zero, the effect size was undefined and 
thus excluded.
 
Effect size=(follow-up – baseline)intervention – 
(follow-up – baseline)control
 
{ follow-up – baseline baseline intervention
follow-up – baseline 
baseline }control
– 
Effect size=100% × 
Articles
e1166 www.thelancet.com/lancetgh   Vol 6   November 2018
For ITS studies, segmented linear regression 
modelling26 was done to estimate a summary effect 
size that incorporated both the level and trend effects 
(appendix 1, pp 52–56). For example, for percentage 
outcomes from a single-arm ITS study, the summary 
effect size was the outcome level at the midpoint of the 
follow-up period as predicted by the regression model 
minus a predicted counterfactual value that equalled the 
outcome level based on the pre-intervention trend 
extended to the midpoint of the follow-up period.
We adjusted effect sizes for contextual and method-
ological factors that might have differed among effect 
sizes and strategy groups (appendix 1, pp 58–61). These 
factors (eg, baseline performance level) were identified 
with random-effects linear regression modelling. The 
purpose of the adjustment was to reduce bias when 
comparing strategies. As the model includes dummy 
variables for the strategy component categories, the 
results also estimate the marginal effect of adding a 
strategy component category.
Estimation of strategy effectiveness
To estimate strategy effectiveness, the effect size for each 
comparison was defined as the median of all effect sizes 
within the comparison.
We stratified results by whether the primary focus of 
the comparison was on improving performance of 
professional health-care providers, who typically work 
in health facilities (eg, physicians, nurses, and 
midwives), or on improving lay or community health 
worker performance. We also stratified results by 
whether or not the comparison was an equivalency 
comparison with a gold standard control group (for 
which an effect size close to zero would be considered a 
successful result).
To compare the effectiveness of different strategies in a 
way that accounts for or reduces bias from outliers, small 
numbers of studies per strategy, unequal sample sizes, 
and methodological and contextual differences among 
the studies, we used a primary and secondary analysis 
(described below), each with advantages and limitations. 
Unless otherwise specified, all analyses were done with 
SAS version 9.4.
Primary analysis
In the primary analysis, each study comparison was 
summarised with a median effect size (MES), and the 
effectiveness of each strategy was described with a 
median of MES values (IQR, range). Medians for 
strategies tested by five or more study comparisons were 
weighted, with weights equal to 1 plus the natural 
logarithm of the number of health-care providers or 
(if number of health-care providers was not reported) 
the number of service provision sites (eg, number of 
health facilities) or (if neither the number of health-
care providers nor the number of service provision sites 
were available) the number of administrative units 
(eg, districts). Strategy groups tested by at least three 
study comparisons (ie, at least three comparisons with 
percentage outcomes or at least three comparisons 
with continuous outcomes) were considered to have 
enough evidence to form generalisable estimates, with 
increasing caution in interpretation as the minimum of 
three comparisons was approached. Strategies tested by 
Panel 1: Definitions of strategy component categories 
Community support
Examples include community health education or social marketing of health services.
Patient support
Examples include patient health education via printed materials or home visits.
Strengthening infrastructure
Examples include provision of medicines or implementation of an improved data 
collection system.
Health-care provider-directed financial incentives
Examples include performance-based payments.
Health system financing and other incentives
Examples include social health insurance or reducing a consultation fee.
Regulation and governance
Examples include accreditation or introducing standard drug quality requirements.
Group problem solving
Examples include collaborative improvement or group problem solving with or without 
formal teams.
Supervision
Examples include improving routine supervision, benchmarking, or audit with feedback.
Other management techniques
These include techniques that do not include group problem solving and supervision 
(which are separate component categories), such as health-care provider 
self-assessment or health-care provider group process that is neither training nor group 
problem solving.
High-intensity training*
Training with a duration greater than 5 days (or ongoing training) and at least one 
interactive educational method (ie, clinical practice, role play, or interactive sessions). This 
category includes academic detailing (ie, one-on-one training by an opinion leader).
Low-intensity training*
Any training that was not categorised as high-intensity training (above). This category 
includes informal education of health-care providers by their peers.
Printed information (including job aids) for health-care providers
This category refers to information that is not an integral part of another component, 
such as a pamphlet. Other strategy components (especially training) often include printed 
information for health-care providers; in these cases, the printed information was not 
considered a separate component.
Information and communication technology for health-care providers
This category includes mHealth and eHealth. Examples include computerised decision 
aids or text message reminders sent to health-care providers’ phones.
See appendix 1 for further details (pp 39–44). *These two categories were combined into a single “any training” category after 
determining that there was no meaningful difference between them in terms of effectiveness.
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fewer than three study comparisons per outcome group 
were interpreted separately.
Four sensitivity analyses were done to examine the 
influence of study bias, limited numbers of comparisons, 
different economic and health facility settings, and the 
effects of weighting and adjustment (see appendix 1 for 
details, p 62). One sensitivity analysis involved broadening 
the strategy definition to increase the contextual and 
implementation diversity of the studies that tested the 
strategy (eg, “information and communication technology 
[ICT] only” was broadened to “ICT with or without other 
strategy components”). This approach is useful when a 
strategy is tested by few studies, and effectiveness is 
unusually large or small.
Secondary analysis
For percentage outcomes only, the secondary analysis 
involved summarising comparisons with an MES, as 
described above, and then a standard random-effects 
meta-analysis (which was an a-priori methodological 
choice) was used to estimate the weighted mean MES and 
95% CI of each strategy.27 To do a meta-analysis, we 
required standard errors for effect sizes that accounted 
for any correlations in the data (eg, patients “clustered” 
within health facilities). We did not use standard errors 
from study reports when investigators did not account for 
data correlations. Instead, we applied some conservative 
assumptions about the correlations (eg, an intraclass 
correlation of 0·4) to the sample size information from 
the studies, and we calculated conservative estimates of 
standard errors (appendix 1, pp 63–74). The secondary 
analysis focuses only on percentage outcomes because in 
the initial version of the HCPPR, sample size information 
needed for standard error calculations was only available 
for percentage outcomes (this information was not in our 
initial data abstraction form and thus required a second 
round of data abstraction).
Role of the funding source
The funders of the study had no role in study design and 
conduct, data collection, data management, data analysis, 
data interpretation, or writing of the report. AKR, the 
corresponding author, had full access to all the reports 
included in the review and had final responsibility for the 
decision to submit for publication.
Results
We screened 216 477 citations (figure 1). After excluding 
205 779 citations and 733 duplicates, we found 9965 reports 
on improving health-care provider performance in LMICs. 
Of these reports, 7696 were excluded, primarily for 
ineligible study designs. Of the remaining 2269 eligible 
reports, 670 were from studies with at least one health-care 
provider practice outcome and a true control group 
(or historical control from single-arm ITS studies). These 
reports, which are the focus of this Article, presented 
results for 337 studies.
The 337 studies comprised 381 comparisons of 
118 strategies (table 1). Of the four strategies tested by the 
minimum number of studies (ten) to evaluate publication 
bias, we found evidence of publication bias for one 
strategy: supervision plus training (asymmetric funnel 
plot and Egger’s test p=0·0017).
The 337 studies represented a diversity of methods, 
geo graphical settings, health-care provider types, work 
environ ments, and health conditions. Appendix 1 
(pp 77–82) summarises study attributes in aggregate, and 
appendix 2 contains citations and details of individual 
studies. The studies were from 64 countries, with 133 
(39·5%) from low-income countries (appendix 1, p 77). 
284 (84·2%) studies were published in 2000 or later. Data 
on strategy costs or other economic evaluations were avail-
able from 125 (37·1%) studies. The studies tested 118 unique 
strategies (table 1), most with multiple inter vention 
components. Risk of bias was low for 54 (16·0%) studies, 
moderate for 84 (24·9%), high for 98 (29·1%), and very 
high for 101 (30·0%). 284 (84·3%) studies had at least one 
Figure 1: Study selection
216 477 citations screened (105 299 from initial version of review plus 111 178 
from update)
58 724 from 52 electronic databases
60 519 from 854 bibliographies of previous reviews and other articles
91 947 from 58 grey literature sources
5287 from other sources
9965 reports identified on improving health-care provider performance in 
low-income and middle-income countries
2269 reports included in the review (824 from initial review plus 1445 from 
update)
670 reports included in the analysis for studies with true controls with at 
least one primary outcome on health-care provider practices
7696 reports excluded
3969 ineligible design
971 no health-care provider strategy
907 full text of report not found
646 review papers 
642 no quantitative data on outcomes 
541 from a high-income country 
13 ineligible strategy comparison 
2 all primary outcomes were difficult to interpret 
5 duplicates
206 512 citations excluded
205 779 excluded on the basis of title and abstract
733 duplicates removed
7 duplicates removed
1592 reports excluded from analysis (no true controls or no 
primary outcomes on health-care provider practices)
See Online for appendix 2
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study report published in a scientific journal, and there 
was no association between risk of bias and publication 
status (p=0·11; appendix 1, p 80). Among 317 studies for 
which study duration could be obtained, follow-up times 
were often short: 1–3 months in 114 (36·0%) studies, 
4–9 months in 107 (33·7%) studies, and 10–73 months in 
96 (30·3%) studies (appendix 1, p 161). We observed wide 
heterogeneity in outcomes, with nearly every study using a 
unique set.
The number of studies increased significantly from the 
1970s to 2010s (figure 2; appendix 1, pp 86, 87). Research 
growth was so substantial that the number of studies per 
year significantly increased for all study categories, 
including study quality. Over time, studies were 
significantly more likely to be from upper-middle-income 
countries and Africa, and more likely to be published in 
a scientific journal. The proportion of studies with a low 
or moderate risk of bias did not significantly change 
over time.
For percentage outcomes, three contextual factors were 
significantly associated with effect size after adjusting for 
strategy component categories: baseline performance, 
settings with only public health facilities, and studies 
from Asia (table 2). For every 1 percentage-point inc-
rease in baseline performance, effect sizes decreased 
by 0·2 percentage points, on average, regardless of the 
strategy to improve performance (appendix 1, p 162). 
When the study setting comprised only public health 
facilities, effect sizes were 6·8 percentage points higher, 
on average. Effect sizes in Asian studies were, on average, 
5·3 percentage points lower than in other continents. We 
therefore adjusted effect sizes for these three factors. The 
adjusted effect sizes reflect a partly standardised study 
context in which baseline performance is 40·1% (ie, mean 
for all effect sizes from percentage outcomes), about 
half (54·5%) of service provision sites are public health 
facilities and half are other settings (eg, private facilities 
and community settings), and 43·1% of settings are in 
Asia. Among the many factors not significantly associated 
with effect size, we present one that is often discussed in 
the literature: the number of components in the strategy 
(appendix 1, pp 163, 164).15,18,28 For continuous outcomes, 
the regression models seemed to be unstable, probably 
because of smaller sample sizes and a wide range of effect 
size values with influential outliers. Similarly, the small 
sample size of studies focused predominantly on lay or 
community health workers was not sufficient to support 
multivariable modelling. We decided not to proceed 
further with modelling for continuous outcomes or for 
outcomes from studies focused predominantly on lay or 
Health-care provider practice outcome scale Totals for percentage and 
continuous outcomes 
combined
Percentage outcomes Continuous outcomes
Professional health-care providers (eg, physicians, nurses, 
midwives, and other health-care providers who typically 
work in health facilities); lay health workers might be 
included, but they are not the primary focus of the study
269 studies*, 101 strategies*, 309 comparisons*, 
and 1297 effect sizes*; median MES 11·5 percentage 
points†‡ (5·1 to 24·6; –19·9 to 77·8)
96 studies§, 53 strategies§, 106 comparisons§, 
and 182 effect sizes§; median MES 11·8 percentage 
points†¶ (–2·2 to 56·9; –90·4 to 615·5)
313 studies, 112 strategies, 
356 comparisons, 
and 1479 effect sizes
Lay health workers are the predominant type of 
health-care provider in the study
18 studies, 14 strategies, 19 comparisons, 
and 189 effect sizes; median MES 8·2 percentage 
points† (4·9 to 12·4; –6·1 to 68·4)
9 studies||, 9 strategies||, 9 comparisons||, 
and 20 effect sizes||; median MES 40·2 percentage 
points†** (23·3 to 99·0; 5·3 to 125·0)
24 studies, 18 strategies, 
25 comparisons, 
and 209 effect sizes
Totals for both health-care provider groups combined 287 studies, 106 strategies, 328 comparisons, 
and 1486 effect sizes
105 studies, 58 strategies, 115 comparisons, 
and 202 effect sizes
337 studies, 118 strategies, 
381 comparisons, 
and 1688 effect sizes
MES=median effect size. *Includes four effect sizes from two comparisons from two studies that were equivalency comparisons with a gold standard control group (equivalency comparisons). †Median 
(IQR; range) of the MES per comparison. Medians for cells with five or more study comparisons were weighted (see Methods). For percentage outcomes among studies for professional health-care providers, 
MES was based on effect sizes adjusted for baseline performance level, public health facility setting only, and study done in Asia. No adjustment for percentage outcomes among studies for lay health-care 
providers or continuous outcomes. ‡Results are for the 307 comparisons that did not involve an equivalency comparison. §Includes six effect sizes from two comparisons from two studies that were equivalency 
comparisons. ¶Results are for the 104 comparisons that did not involve an equivalency comparison. ||Includes one effect size from one comparison in one study that was an equivalency comparison. **Results 
are for the eight comparisons that did not involve an equivalency comparison.
Table 1: Number of studies, strategies, comparisons, effect sizes, and distribution of median effect size values for each health-care provider group, stratified by outcome scale
Figure 2: Number and risk of bias of studies with acceptable research designs* over time
*Study designs eligible for the review included pre-intervention versus post-intervention studies with a randomised 
or non-randomised comparison group, post-intervention only studies with a randomised comparison group, 
and interrupted time series with at least three datapoints before and after the intervention.
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community health workers; thus, no adjustments were 
made for their effect sizes.
Among studies of professional health-care providers, for 
percentage outcomes, the median MES across all 307 study 
comparisons (excluding equivalency comparisons) was an 
improvement of 11·5 percentage points (IQR 5·1 to 24·6; 
range –19·9 to 77·8; table 1). For continuous outcomes, 
the median MES across all 104 study comparisons 
(excluding equivalency comparisons) was an improvement 
of 11·8 percentage points (IQR –2·2 to 56·9; range –90·4 to 
615·5), highlighting that extreme results can occur with 
effect sizes based on relative changes. Among studies 
predominantly done with lay or community health-care 
providers, the median MES for percentage outcomes was 
8·2 percentage points and that for continuous outcomes 
was 40·2 percentage points (table 1).
In table 2, the parameter estimate for a given strategy 
component category dummy variable is the mean effect 
of strategies with the component category minus the 
mean effect of strategies without the component 
category, adjusted for all other factors in the model. 
Two strategy component categories were associated with 
greatest effectiveness: any training (marginal effect size 
of 6·4 percentage points) and group problem solving 
(marginal effect size of 13·6 percentage points). These 
findings suggest that training health-care providers and 
group problem solving might be useful components 
in any strategy.
The effectiveness of specific strategies is shown for 
non-equivalency studies. The four equivalency studies 
are presented in appendix 1 (pp 159, 160). For brevity, we 
use the term “effect” to denote strategy effectiveness in 
terms of the median MES. As qualitative descriptors of 
effect, “small effects” corresponds to improvements of 
less than 5 percentage points, “modest” corresponds to 
about 5–10 percentage points, “moderate” corresponds 
to about 10–20 percentage points, “large” corresponds 
to about 20–30 percentage points, and “very large” 
corresponds to greater than 30 percentage points.
Among 353 comparisons from 310 studies of 
professional health-care providers, we identified 
111 unique strategies (table 3; appendix 1, pp 111–23). 
Among the 101 strategies tested with percentage 
outcomes, the GRADE-based QOE on effectiveness was 
high for two (2·0%) strategies, moderate for 20 (19·8%), 
low for 26 (25·7%), and very low for 53 (52·5%). Among 
the 51 strategies tested with continuous outcomes, the 
corresponding QOE proportions were high for two 
(3·9%), moderate for ten (19·6%), low for 15 (29·4%), 
and very low for 24 (47·1%). Most strategies 
(88 [79·3%] of 111) were tested by fewer than three study 
comparisons for both outcome types (ie, percentage and 
continuous outcomes; appendix 1, pp 111–23). Thus, the 
general isability of these results is limited.
The effectiveness of the 24 strategies tested by at least 
three comparisons for percentage or continuous outcomes 
is shown in table 3. First, effect sizes varied widely in most 
strategy groups (with greater within-strategy heterogeneity 
than between-strategy heterogeneity). Thus, one cannot 
generally conclude that one strategy is definitively more 
effective than another or predict the effectiveness for any 
strategy. 
Second, two strategies used alone had median MES 
values close to zero: printed information or job aids for 
health-care providers, and ICT for health-care providers 
(low to moderate QOE for percentage and continuous 
outcomes; table 3). These findings were supported by 
the sensitivity analysis that only included studies with 
a low or moderate risk of bias (low to high QOE; 
appendix 1, pp 131–38). As few studies tested ICT in 
isolation (and the study with continuous outcomes 
found unexpectedly large negative effects), we explored a 
broadened strategy definition of “ICT with or without 
Parameter estimate 
(95% CI)
p value*
Intercept 7·6 (2·1 to 13·1) 0·01
Dummy variables† that each code for a strategy component category
Community support 0·3 (–5·0 to 5·6) 0·92
Patient support –3·6 (–9·5 to 2·2) 0·22
Strengthening infrastructure –1·2 (–7·2 to 4·9) 0·71
Health-care provider-directed 
financial incentives
6·1 (–6·5 to 18·6) 0·34
Health system financing and other 
incentives
2·5 (–3·4 to 8·5) 0·40
Regulation and governance 2·7 (–4·3 to 9·7) 0·45
Group problem solving 13·6 (5·7 to 21·6) 0·001
Supervision 1·0 (–1·8 to 3·9) 0·48
Other management techniques 3·3 (–1·8 to 8·5) 0·21
Any training 6·4 (1·5 to 11·2) 0·01
Printed information or job aid for 
health-care providers
–1·0 (–6·6 to 4·6) 0·72
Information and communication 
technology for health-care providers
–2·4 (–8·6 to 3·8) 0·44
Contextual factors‡ for effect size adjustment (all mean-centred)
Baseline performance level –0·2 (–0·2 to –0·1) <0·0001
Public health facility setting only (vs 
other settings)
6·8 (2·6 to 10·9) 0·002
Country was in Asia –5·3 (–9·2 to –1·4) 0·01
*Based on score statistics for type 3 tests of fixed effects, which tend to give 
conservative estimates. The one exception is the p value of the intercept, based on 
the t test, which tends to give less conservative estimates. This is the only p value 
provided in the SAS output for the intercept. The conclusion of the test (significant 
or not, based on a 0·05 cutoff) from the two sets of p values (t test vs type 3 test) 
always agreed. †Dichotomous variable with a value of one if the strategy included 
a component from a given strategy component category (eg, training), otherwise 
the variable has a value of zero. The parameter estimate is the mean effect of the 
strategy component category, adjusted for other components in the strategy and 
contextual factors in the model. ‡Baseline performance is a continuous variable, 
and public health facility setting only and Asian country are dichotomous 
variables. The adjusted R-square of the model was 0·05567 without contextual 
factors and 0·2155 with contextual factors.
Table 2: Model to estimate strategy component effectiveness and 
identify contextual factors associated with effect size for practice 
outcomes expressed as a percentage from studies of professional 
health-care providers
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Practice outcomes expressed as a percentage Continuous practice outcomes
Number of 
study 
comparisons 
(studies 
with low or 
moderate 
risk of bias)
Number 
of 
countries 
studied
Median MES based on adjusted 
effect sizes* (IQR; range)
GRADE 
quality of 
evidence
Number of 
study 
comparisons 
(studies 
with low or 
moderate 
risk of bias)
Number 
of 
countries 
studied
Median MES based on unadjusted 
effect sizes (IQR; range)
GRADE 
quality of 
evidence
Studies focused on professional health-care providers (descending order of effect size for percentage outcomes†)
Community support plus strengthening 
infrastructure plus supervision plus other 
management techniques plus any training
0 (0) 0 NA NA 3 (1) 3 76·1 (NA; 73·9 to 153·0) Moderate
Strengthening infrastructure plus health 
system financing and other incentives plus 
supervision plus other management 
techniques plus any training
3 (1) 2 57·7 (NA; 4·4 to 58·7) Moderate 0 (0) 0 NA NA
Group problem solving plus any training 4 (1) 2 56·0 (40·9 to 68·6; 29·2 to 77·8) Moderate 1 (1) 1 52·4 Moderate
Strengthening infrastructure plus 
supervision plus other management 
techniques plus any training
2 (2) 2 33·1 (NA; 29·4 to 36·7) Low 4 (1) 4 183·2 (63·2 to 456·3; 56·9 to 615·5) Moderate
Group problem solving only 12 (3) 10 28·0 (12·1 to 41·7; 5·5 to 61·2) Low 4 (0) 3 –8·1 (–24·3 to 44·2; –28·2 to 84·1) Low
Community support plus supervision 
plus any training
4 (2) 4 20·7 (7·5 to 24·3; –2·9 to 25·3) Low 0 (0) 0 NA NA
Other management techniques plus 
printed information or job aid for HCPs
2 (2) 2 18·2 (NA; 4·7 to 31·8) Low 3 (3) 3 11·8 (NA; 0·3 to 16·5) Moderate
Supervision plus any training 26 (11) 17 18·0 (6·0 to 25·2; –2·7 to 67·0) Very low 8 (3) 5 11·1 (7·3 to 60·4; –16·3 to 101·1) Low
Other management techniques only 4 (3) 3 16·5 (2·3 to 21·3; –11·1 to 25·3) Moderate 0 (0) 0 NA NA
Other management techniques plus any 
training
5 (1) 4 15·9 (2·8 to 23·9; –1·7 to 54·2) Low 2 (0) 2 9·1 (NA; 8·3 to 9·9) Very low
Community support plus any training 4 (0) 4 15·1 (9·0 to 25·0; 8·2 to 29·6) Very low 1 (1) 1 4·5 Low
Supervision only 16 (8) 12 14·8 (6·2 to 25·2; –6·1 to 56·3) Moderate 3 (1) 3 –3·0 (NA; –90·4 to 31·4) Low
Strengthening infrastructure only 3 (3) 3 13·0 (NA; –7·0 to 15·8) Moderate 2 (2) 2 152·1 (NA; 4·2 to 300·0) Moderate
Supervision plus other management 
techniques plus any training
5 (2) 4 11·4 (0·7, 11·4; –16·2 to 26·7) Low 2 (2) 2 30·1 (NA; 28·3 to 31·9) Low
Patient support plus any training 6 (3) 6 11·2 (2·6 to 15·3; –6·4 to 31·5) Low 1 (0) 1 73·3 Very low
Any training only 78 (33) 31 10·3 (6·1 to 20·7; –19·9 to 60·8) Low 16 (8) 10 17·5 (0·1 to 23·7; –25·0 to 81·4) Low
Strengthening infrastructure plus 
supervision plus any training
4 (1) 4 8·9 (–0·8 to 39·8; –4·8 to 64·9) Low 4 (4) 3 64·3 (31·9 to 88·7; 2·6 to 110·1) High
Supervision plus other management 
techniques
4 (0) 3 7·7 (–1·3 to 11·7; –7·9 to 13·3) Very low 2 (0) 2 94·3 (NA; –9·2 to 197·9) Very low
Group problem solving plus information 
and communication technology for HCPs
3 (3) 3 6·7 (NA; –3·5 to 32·6) High 0 (0) 0 NA NA
Supervision plus printed information or 
job aid for HCPs
3 (3) 7 2·3 (NA; 2·1 to 24·4) Moderate 3 (1) 3 –3·7 (NA; –7·1 to 16·7) Low
Printed information or job aid for HCPs 
only
8 (5) 7 1·4 (–4·8 to 6·2; –13·7 to 11·6) Moderate 3 (1) 2 –3·4 (NA; –72·0 to 6·5) Moderate
Strengthening infrastructure plus 
supervision plus any training plus 
information and communication 
technology for HCPs
3 (2) 3 1·3 (NA; –1·7 to 20·1) Moderate 0 (0) 0 NA NA
Health system financing and other 
incentives only
2 (0) 2 1·2 (NA; –2·6 to 5·0) Very low 3 (2) 2 20·4 (NA; –23·9 to 72·4) Moderate
Information and communication 
technology for HCPs only
4 (4) 3 1·0 (–2·8 to 9·9; –2·9 to 15·1) Moderate 1 (1) 1 –38·9 Low
Studies predominantly of lay or community health workers*
Any training only 4 (0) 3 2·4* (–1·1 to 7·4; –1·2 to 9·1) Low 0 0 NA NA
Strategies tested by at least three comparisons with percentage outcomes or at least three comparisons with continuous outcomes. GRADE=Grading of Recommendations Assessment, Development, and 
Evaluation system. MES=median effect size. NA=not applicable. HCP=health-care provider. *Effect sizes expressed as an absolute percentage-point change. See Methods section for details on adjustment. Effect 
sizes from studies of predominantly lay or community health workers are not adjusted. †Unless no studies with percentage outcomes were found, in which case results of continuous outcomes were used.
Table 3: Effectiveness of strategies to improve health-care provider performance for studies with at least one practice outcome
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other strategy components” to increase contextual and 
implementation diversity (appendix 1, p 62). We found 
28 studies with percentage outcomes (the four original 
“ICT only” studies plus 24 additional ICT studies; 
median MES 8·4 percentage points [IQR 4·7 to 16·0, 
range –3·5 to 59·4]) and four studies with continuous 
outcomes (median MES –0·2 percentage points [–19·6 
to 18·2, –38·9 to 36·4]; appendix 1, p 143). 
Third, the effects of the frequently used strategies of 
training or supervision as sole strategies tended to be 
moderate. Effects for training only were 10·3 percentage 
points for percentage outcomes and 17·5 percentage 
points for continuous outcomes (low QOE; table 3), 
with almost identical results from the sensitivity analysis 
of low or moderate risk-of-bias studies (10·3 percentage 
points for percentage outcomes [IQR 7·3 to 20·7, 
range –7·1 to 50·6] and 17·4 percentage points for 
continuous outcomes [–7·7 to 23·7, –25·0 to 81·4], with 
moderate QOE). For supervision only, assessed with 
percentage outcomes, the effects were 14·8 percentage 
points (moderate QOE; table 3) from the main analysis 
and 15·9 percentage points (IQR 5·1 to 25·2, range 0·03 
to 40·4; high QOE) from the sensitivity analysis. However, 
effects from continuous outcomes were inconsistent 
and highly variable (–3·0 percentage points from 
three studies; IQR not applicable [NA], range –90·4 to 
31·4; low QOE). The combination of training and 
supervision had somewhat larger effects than either 
strategy alone when assessed with percentage outcomes: 
18·0 percentage points (very low QOE) from the main 
analysis and 18·8 per centage points (IQR 11·3 to 24·7, 
range 5·8 to 30·8; moderate QOE) from the sensitivity 
analysis. Effects from continuous outcomes were lower: 
11·1 per centage points (low QOE) from the main analysis 
and –2·2 percentage points (IQR NA, range –16·3 to 7·3; 
moderate QOE) from the sensitivity analysis.
Fourth, group problem solving alone typically had large 
effects when assessed with percentage outcomes: 
28·0 percentage points (low QOE) from the main 
analysis and 37·5 percentage points (IQR NA, range 5·5 
to 61·2; moderate QOE) from the sensitivity analysis. 
However, effects from continuous outcomes were 
inconsistent and highly variable (–8·1 percentage points; 
IQR –24·3 to 44·2, range –28·2 to 84·1; low QOE; 
table 3). To explore a broadened strategy definition (group 
problem solving with or without other strategy 
components) to increase contextual and implementation 
diversity, we found 23 studies with percentage outcomes 
(median MES 12·1 percentage points, IQR 6·2 to 37·5, 
range –3·5 to 72·5) and eight studies with continuous 
outcomes (3·5 percentage points, –2·2 to 84·1, –28·2 to 
375·2; appendix 1, p 142).
Fifth, we identified three strategies with very large effect 
sizes that were tested by few studies that mostly had a 
high risk of bias: the combination of strengthened infra-
structure, financing, supervision, management tech-
niques, and training; group problem solving plus training; 
and the combination of strengthened infrastructure, 
supervision, management techniques, and training 
(table 3). The combination of strengthened infrastructure, 
financing, supervision, management tech niques, and 
training had a median MES of 57·7 percentage points 
from three studies with percentage outcomes (moderate 
QOE; table 3). However, a broadened definition of nine 
studies, which allowed other components to be added to 
the core strategy, revealed substantially lower effects of 
32·8 percentage points (IQR 6·6 to 58·7, range 4·4 to 
60·6; appendix 1, p 141). Median MES for group problem 
solving plus training was 56·0 percentage points from 
four studies with percentage outcomes (moderate QOE; 
table 3). A broadened definition of 14 studies yielded 
substantially lower effects of 16·1 percentage points 
(IQR 10·2 to 34·9, range 1·5 to 77·8; appendix 1, p 141). 
The combination of strengthened infrastructure, 
supervision, management techniques, and training had 
effects of 33·1 percentage points from two studies with 
percentage outcomes (low QOE) and 183·2 percentage 
points from four studies with continuous outcomes 
(moderate QOE; table 3). A broadened definition of 
17 studies with percentage outcomes led to similar effects 
of 29·4 percentage points (IQR 10·7 to 36·9, range 4·4 
to 60·6), and a broadened definition of nine studies with 
continuous outcomes found reduced (but still large) 
effects of 76·1 percentage points (69·4 to 297·1, –7·4 to 
615·5; appendix 1, p 141).
Finally, we examined three strategies that were tested 
by fewer than three studies (appendix 1, pp 111–23) 
but that have received much attention in recent 
years: financial incentives for health-care providers, 
other financing and incentives, and strategies targeting 
regu lation and governance.2 Financial incentives for 
health-care providers as a sole strategy were tested 
by two studies with percentage outcomes (median 
MES 26·0 percentage points) and by one study with 
continu ous outcomes (MES 66·7 percentage points; 
appendix 1, p 114). Effects from a broadened definition of 
ten studies with percentage outcomes were substantially 
lower (7·2 percentage points, IQR 6·6 to 40·8, range 5·0 
to 60·6), as were effects from a broadened definition of 
eight studies with continuous outcomes (18·9 percentage 
points, 3·5 to 66·7, –29·3 to 375·2; appendix 1, p 143). 
Health system financing and other incentives as a sole 
strategy were tested by two studies with percentage 
outcomes (median MES 1·2 percentage points) and 
by three studies with continuous outcomes (median 
MES 20·4 percentage points; table 3). Effects from a 
broadened definition of 38 studies with percentage 
outcomes were larger (14·2 percentage points, IQR 7·2 
to 28·8, range –2·9 to 60·6), and effects from a 
broadened definition of 23 studies with continuous 
outcomes were lower (5·9 percentage points, –0·4 to 
20·4, –25·4 to 375·2; appendix 1, p 143). We found no 
studies of regulation and governance as a sole strategy. 
Effects from a broadened definition of ten studies with 
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percentage outcomes were large (27·6 percentage points, 
IQR 3·9 to 36·9, range –0·8 to 60·6), as were effects 
from a broadened definition of five studies with 
continuous outcomes (20·3 percentage points, 3·5 to 
70·0, 3·5 to 121·3; appendix 1, p 143). 
To characterise the contexts in which a strategy might 
be more effective, we stratified results of percentage 
outcomes according to the level of resources of the setting 
where the study was done (appendix 1, p 62). Results for 
strategies tested with at least three comparisons in each 
resource level are presented in appendix 1 (pp 145, 146). 
For three strategies (group problem solving only, patient 
support plus training, and supervision plus training), 
the effects were larger by at least 10 percentage points 
in moderate-resource settings compared with low-
resource settings. For the remaining three strategies, 
effect differences between the two resource strata were 
less than 10 percentage points. A similar analysis found 
larger effect sizes in studies of inpatient-only settings 
compared with outpatient-only settings for training only 
(inpatient median MES 20·7 percentage points [11 study 
comparisons], outpatient median MES 9·0 percentage 
points [45 study comparisons]) and for supervision plus 
training (inpatient median MES 24·7 percentage points 
[three study comparisons], outpatient median MES 
18·8 percentage points [21 study comparisons]).
Results of the fourth sensitivity analysis, in which we 
analysed effectiveness with unadjusted and unweighted 
effect sizes, and the meta-analysis are presented in 
appendix 1 (pp 147–58).
Among the 18 strategies that predominantly targeted 
lay health workers, only one was tested by at least 
three study comparisons: any training as a sole strategy 
(median MES 2·4 percentage points; low QOE; table 3). 
Strategies that included community support plus 
training, with or without other components, tended to 
have larger effect sizes. Five strategies were assessed 
with percentage outcomes (range 8·2 to 56·2 percen-
tage points; very low to moderate QOE; appendix 1, 
pp 124–26), and four were assessed with continuous 
outcomes (range 23·3 to 125·0 percentage points; very 
low to moderate QOE; appendix 1, pp 124–26).
Discussion
Our goal was to identify effective strategies for improving 
health-care provider performance in LMICs. Improved 
health-care provider performance should lead to stronger 
health systems and better health outcomes for individuals 
and populations. To the best of our knowledge, the 
HCPPR is the most comprehensive review on this topic.
The first main conclusion was that a large number of 
studies (n=337) exist with relatively robust study designs 
on the effectiveness of strategies to improve health-care 
provider practices in LMICs. These studies evaluated a 
diversity of strategies (n=118) to improve performance 
for numerous health conditions, which were tested in a 
wide variety of settings. The task of synthesising the 
results was greatly complicated by the methodological 
and contextual heterogeneity of the studies, heterogeneity 
of interventions within strategy groups, and short-
comings of the evidence base. In particular, the majority 
of strategies were tested by a single study, which limits 
generalisability; studies generally had short follow-up 
times, which reduces their relevance to programmes that 
require strategies with sustained effect; and most studies 
had a high risk of bias, which contributed to the low 
evidence quality for most strategies.
Second, we identified several cross-cutting findings 
about strategy effectiveness. Two strategy component 
categories had significant marginal effects: group problem 
solving and training. We found that effectiveness was 
unrelated to the number of components in the strategy. 
We observed substantial variation in effect sizes within 
most strategies, including inconsistencies between MES 
values from percentage and continuous outcomes (and 
sometimes large variability for continuous outcomes), 
which raises questions about the utility of continuous 
outcomes in this systematic review. These inconsistencies 
are likely to be due to differences in outcome definitions, 
measurement methods, and how effect sizes are calculated 
(especially the relative change for continuous outcomes 
[equation 2], which can lead to very large effect sizes when 
baseline values are small). Potential causes of within-
strategy heterogeneity of effect sizes include contextual 
variability, methodological differences (eg, outcomes for 
practices with varying degrees of difficulty, and differences 
in measurement methods), heterogeneity of strategies 
within our categories (eg, community supports varied 
substantially; appendix 1, pp 39, 40), implementation 
heterogeneity (eg, varying strength of implementation, 
and modification of the strategy over time), study biases 
(eg, unreliable outcomes, data quality changing over 
time, and error from non-representative samples), and 
imprecision from small sample sizes. The variability of 
effect sizes demonstrates the difficulty in predicting the 
effectiveness of any strategy and suggests that it is 
important to monitor actual effects in a given practice 
setting.
Third, our results support several conclusions about 
the effectiveness of strategies to improve practices of 
professional health-care providers. Among strategies 
assessed by percentage outcomes, most (87 [86·1%] of 
101) had median MES values less than 30 percentage 
points, which means that even after implementing 
improvement strategies, important performance gaps 
will probably remain. Assuming typical baseline 
performance of 40% and an optimistic strategy effect of 
30 percentage points, post-intervention performance 
would be 70% (ie, 40 plus 30 percentage points), or about 
a third of patients not receiving recommended care.
With regard to specific strategies, we found that printed 
information or job aids for health-care providers only 
and ICT for health-care providers (alone or combined 
with other components) typically had small to modest 
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effects. The often-used strategies of supervision only and 
training only tended to have moderate effects. Compared 
with training in isolation, effect sizes were generally 
larger when training was combined with other strategies, 
such as supervision and group problem solving. Group 
problem solving only can have large effects, but a more 
comprehensive assessment (based on a broadened 
definition) suggests that it has moderate effectiveness. 
Two specific multifaceted strategies targeting infra-
structure, supervision, other management techniques, 
and training (with and without financing), and the 
combination of group problem solving and training often 
had large effects. Financial incentives for health-care 
providers had modest to moderate effects, as did health 
system financing and other incentives. Studies of 
regulation and governance strategies tended to have 
large effects, but they were not studied in isolation; thus 
it is difficult to know how much these improvements 
were due to the impact of other strategy components 
(usually including training or supervision or both, which 
typically have moderate effects of their own). Our 
analyses also suggest that certain strategies (eg, group 
problem solving, and training with either patient support 
or supervision) might be more effective in areas with 
higher levels of resources than in low-resource settings 
(appendix 1, pp 145, 146), and other strategies (eg, training 
only or supervision plus training) might be more effective 
in inpatient settings than in outpatient settings. However, 
the types of practices and intervention approaches in 
inpatient and outpatient settings are quite different.
Several of these conclusions were informed by the 
sensitivity analysis that broadened a strategy’s definition. 
When effects from a broadened definition with a larger 
number of studies are lower than those from a narrow 
definition, they might better reflect typical improvements 
in a programmatic setting.
Finally, we identified few studies examining strategies 
to improve lay or community health worker practices, 
Panel 2: Guidance on improving health-care provider practices in low-income and middle-income countries
General guidance on improving health-care provider practices
• The effects of any strategy should be monitored so that 
managers can know how well it is working. Monitoring data 
could be used to adapt strategies to local conditions and to 
facilitate learning as implementation proceeds, with the aim 
of increasing effectiveness.
• A general approach to improving health-care provider 
practices is for programmes to implement an initial strategy 
(based on research evidence and knowledge of the local 
context), monitor health-care provider practices, address 
gaps (which are to be expected) by modifying or 
abandoning the strategy or layering on a new one, and 
continue to monitor and modify as needed.*
• Decision makers should not assume that increasing the 
number of strategy components will increase a strategy’s 
effectiveness.
• Any strategy might benefit from including training or group 
problem solving as a component, although training by itself 
is only moderately effective.
Guidance for professional health-care providers (ie, in settings 
that do not only include lay health workers)
• Providing printed information or job aids to health-care 
providers as a sole strategy is unlikely to substantially 
change performance.
• Information and communication technology might lead to 
moderately large improvements or no improvement, but it 
typically has small-to-modest effects.
• Training only or supervision only might produce large 
improvements or no improvement, but both strategies 
generally tend to have moderate effects. It might be more 
effective to combine training with other strategies, such as 
supervision or group problem solving.
• Group problem solving only might bring about large or 
small improvements, but moderate effects are more typical.
• Multifaceted strategies targeting infrastructure, supervision, 
other management techniques, and training (with and 
without financing), and the strategy of group problem 
solving plus training might result in very large or only modest 
improvements, but such strategies tend to have large effects.
• Financial incentives for health-care providers, and health 
system financing strategies and other incentives might lead 
to large or small improvements, but these incentives 
typically have modest to moderate effects.
• The effects of regulation and governance strategies in 
isolation are unknown. When combined with other 
components, they tended to have large effects; however, 
it is difficult to know how much these improvements were 
due to the effect of other strategy components.
• Programmes might benefit from considering the influence 
of context on strategy effectiveness. Certain strategies 
(eg, group problem solving, and training with either patient 
support or supervision) might be more effective in areas 
with higher levels of resources.† Other strategies 
(eg, training only or supervision plus training) might be 
more effective in inpatient settings.
Guidance for settings with only lay health workers
• Training health-care providers as a sole strategy might 
produce modest improvements, but effects are usually small.
• Strategies that include community support plus training for 
health-care providers might lead to large improvements, 
although the evidence is limited.
*We acknowledge that the step on addressing gaps is partly a hypothesis that should be 
tested, but it is also partly justified by the relatively large effect sizes found for group 
problem-solving strategies that involve cycles of monitoring performance and making 
adjustments for further improvement. †Hospitals in low-income countries and areas in 
middle-income countries that are not entirely rural.
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and many of these studies had a high risk of bias. 
Training lay health workers seemed to have a small effect 
size, and combining training with community support 
might be more effective.
For strategies examined by the HCPPR and other 
systematic reviews, results are generally similar. For 
example, median effect sizes from the review by 
Holloway and colleagues,6 which only included studies 
from LMICs, were generally consistent with our results 
for training only, supervision only, printed information 
for health-care providers only, health-care provider 
training and community education, and health-care 
provider training plus supervision plus patient or 
community education. Our results matched those of 
reviews that included studies primarily from high-
income countries for training only,29 printed information 
for health-care providers only,30 collaborative improve-
ment14 (which was in our group problem solving 
category, if our more comprehensive assessment 
with broadened definitions is considered), audit with 
feedback31 (which was in our supervision category; 
panel 1), and the absence of association between number 
of strategy components and effect sizes.15,28 We had 
difficulty comparing our results on training of lay health 
workers with those of the review by Sorsdahl and 
colleagues32 because that review only included two 
studies that had divergent results.
The HCPPR has several important limitations. First, 
many included studies had notable shortcomings, such as 
inadequate detail about strategy and context (including 
how and why strategies were chosen), heterogeneity of 
strategy implementation approaches and outcomes, 
difficulty in assessing study precision and strength of 
implementation, and high risk of bias. Second, our 
analytical approach, which we intentionally designed to 
identify broad patterns across all studies, meant that 
results do not reflect some important nuances. For 
example, all ICT strategies were considered equivalent. 
Future analyses will benefit from more specific 
classification (eg, separating results of different ICT 
strategies). Third, our analysis of the effect of study context 
was simplistic, as resource levels based on rurality and 
national economic category might not represent resource 
levels at the actual study sites. Fourth, meta-analyses have 
some well recognised limitations.33,34 Finally, as study 
settings often benefit from extra resources and the 
attention of investigators, it is difficult to know the degree 
to which study results can be generalised to non-study 
settings or replicated when brought to scale.35
Practical, evidence-based guidance about improving 
health-care provider practices in LMICs is presented in 
panel 2. The statements are worded cautiously because, 
in addition to the limitations mentioned previously, 
decisions about which strategies a programme should 
use in a given setting depend on many factors, such as 
effectiveness, cost, feasibility, and political and cultural 
acceptability. This report only presents information about 
strategy effectiveness. Recommendations for future 
research are presented in panel 3. These recommen-
dations emphasise the importance of more standardised 
methods, stronger study designs, replication research, 
and a better understanding of the influence of context on 
strategy effectiveness.
In conclusion, a large evidence base exists to 
demonstrate the effectiveness of strategies to improve 
health-care provider practices in LMICs. We found that 
strategy effectiveness varied substantially, that some 
strategies seem more effective than others, and that some 
strategies might be better suited to certain settings. Future 
analyses will examine strategy effectiveness for other 
outcomes (eg, patient health outcomes and use of health 
services), head-to-head comparisons, the effect of time on 
strategy effect, cost, and strategy attributes associated with 
effectiveness. We encourage the use of the HCPPR’s 
publicly available database for focused analyses that might 
be relevant to specific programmes. Results from the 
HCPPR should inform decision making about improving 
health-care provider performance in LMICs.
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• Prioritise replication studies, especially for strategies with weak supporting evidence 
and (based on what is known) large effect sizes (eg, training plus group problem-
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community health workers
• Consider ways to better use routinely collected data to evaluate strategies, as the use 
of existing data could reduce the time and cost of studies
• If resources allow it, consider replacing true control groups with a comparison group 
that receives a simple strategy that is likely to improve health-care provider 
performance, such as training only (with effects similar to the median of all strategies; 
table 1), to increase the likelihood that all patients and health-care providers benefit 
from participating in studies
For the HCPPR’s publicly 
available database see 
http://www.
hcpperformancereview.com
Articles
www.thelancet.com/lancetgh   Vol 6   November 2018 e1175
initial draft of the manuscript. All authors contributed substantially to 
the analysis, interpretation of the results, and completion of the 
manuscript. All authors approved the final manuscript. 
Declaration of interests
We declare no competing interests. 
Acknowledgments
This systematic review was supported by funding from the CDC 
Foundation through a grant from the Bill & Melinda Gates Foundation 
(grant OPP52730), and from the US Centers for Disease Control and 
Prevention (CDC), and a World Bank–Netherlands Partnership Program 
Grant (project number P098685). The findings and conclusions 
presented in this report are those of the authors and do not necessarily 
reflect the official position of the CDC and the CDC Foundation. We are 
grateful for the excellent assistance from the data abstractors from the 
update of the review (Sushama Acharya, Gordon Akudibillah, 
Stacy Harmon, Mbabazi Kariisa, Sonia Menon, and 
Scholastique Nikuze), as well as the data abstractors from the original 
phase of the review. We also thank the librarians, statistical advisers, 
and data managers who worked on this review; the responses that 
hundreds of authors provided to our questions about their studies; and 
the thoughtful suggestions provided by those who attended meetings in 
which preliminary results were presented from 2012 to 2014: in Beijing, 
at the Second Global Symposium on Health Systems Research; in 
London, at the London School of Hygiene & Tropical Medicine; in 
Geneva, at WHO; in Sweden, at the Karolinska Institute; and in Oslo, 
at the Norwegian Knowledge Centre for the Health Services. This Article 
is based on information in the HCPPR, a joint programme of the CDC, 
Harvard Medical School, WHO, Management Sciences for Health, 
Johns Hopkins University, and the CDC Foundation. 
References
1 Countdown to 2030 Collaboration. Countdown to 2030: tracking 
progress towards universal coverage for reproductive, maternal, 
newborn, and child health. Lancet 2018; 391: 1538–48.
2 Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems 
in the Sustainable Development Goals era: time for a revolution. 
Lancet Glob Health 2018. Published online Sept 5. 
http://dx.doi.org/10.1016/S2214-109X(18)30386-3.
3 English M, Gathara D, Mwinga S, et al. Adoption of recommended 
practices and basic technologies in a low-income setting. 
Arch Dis Child 2014; 99: 452–56.
4 Hill J, D’Mello-Guyett L, Hoyt J, van Eijk A, ter Kuile F, Webster J. 
Women’s access and provider practices for the case management of 
malaria during pregnancy: a systematic review and meta-analysis. 
PLoS Med 2014; 11: e1001688.
5 Hogerzeil HV, Liberman J, Wirtz VJ, et al. Promotion of access to 
essential medicines for non-communicable diseases: practical 
implications of the UN political declaration. Lancet 2013; 381: 680–89.
6 Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, 
Ross-Degnan D. Have we improved use of medicines in developing 
and transitional countries and do we know how to? Two decades of 
evidence. Trop Med Int Health 2013; 18: 656–64.
7 Maher D, Ford N, Unwin N. Priorities for developing countries in 
the global response to non-communicable diseases. Global Health 
2012; 8: 14.
8 Merali H, Lipsitz S, Hevelone N, et al. Audit-identified avoidable 
factors in maternal and perinatal deaths in low resource settings: 
a systematic review. BMC Pregnancy Childbirth 2014; 14: 280.
9 Saleem S, McClure E, Goudar S, et al. A prospective study of 
maternal, fetal and neonatal deaths in low- and middle-income 
countries. Bull World Health Organ 2014; 92: 605–12.
10 Nguyen DTK, Leung KK, McIntyre L, Ghali WA, Sauve R. 
Does integrated management of childhood illness (IMCI) training 
improve the skills of health workers? A systematic review and 
meta-analysis. PLoS One 2013; 8: e66030.
11 Lewin S, Munabi-Babigumira S, Glenton C, et al. Lay health 
workers in primary and community health care for maternal and 
child health and the management of infectious diseases. 
Cochrane Database Syst Rev 2010; 2010: CD004015.
12 Bosch-Capblanch X, Liaqat S, Garner P. Managerial supervision to 
improve primary health care in low- and middle-income countries. 
Cochrane Database Syst Rev 2011; 2011: CD006413.
13 Witter S, Fretheim A, Kessy FL, Lindahl AK. Paying for performance 
to improve the delivery of health interventions in low- and 
middle-income countries. Cochrane Database Syst Rev 2012; 
2012: CD007899.
14 Wells S, Tamir O, Gray J, Naidoo D, Bekhit M, Goldmann D. 
Are quality improvement collaboratives effective? A systematic 
review. BMJ Qual Saf 2017; 27: 226–40
15 Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and 
efficiency of guideline dissemination and implementation 
strategies. Health Technol Assess 2004; 8: iii–iv, 1–72.
16 Ciapponi A, Lewin S, Herrera CA, et al. Delivery arrangements for 
health systems in low-income countries: an overview of systematic 
reviews. Cochrane Database Syst Rev 2017; 2017: CD011083.
17 Herrera CA, Lewin S, Paulsen E, et al. Governance arrangements for 
health systems in low-income countries: an overview of systematic 
reviews. Cochrane Database Syst Rev 2017; 2017: CD011085.
18 Pantoja T, Opiyo N, Lewin S, et al. Implementation strategies for 
health systems in low-income countries: an overview of systematic 
reviews. Cochrane Database Syst Rev 2017; 2017: CD011086.
19 Wiysonge CS, Paulsen E, Lewin S, et al. Financial arrangements for 
health systems in low-income countries: an overview of systematic 
reviews. Cochrane Database Syst Rev 2017; 2017: CD011084.
20 WHO. Working together for health. World Health Report 2006. 
Geneva: World Health Organization, 2006.
21 Rowe AK, Labadie G, Jackson D, Vivas-Torrealba C, Simon J. 
Improving health worker performance: an ongoing challenge for 
meeting the sustainable development goals. BMJ 2018; 362: k2813.
22 Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: 
the PRISMA statement. PLoS Med 2009; 6: e1000097.
23 Effective Practice and Organisation of Care (EPOC). Suggested risk 
of bias criteria for EPOC reviews. EPOC Resources for review 
authors. Oslo: Norwegian Knowledge Centre for the Health 
Services, 2015. http://epoc.cochrane.org/epoc-specific-resources-
review-authors (accessed June 19, 2015).
24 Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. 
Introduction—GRADE evidence profiles and summary of findings 
tables. J Clin Epidemiol 2011; 64: 383–94.
25 Egger M, Davey Smith G, Schneider M, Minder C. Bias in 
meta-analysis detected by a simple, graphical test. BMJ 1997; 
315: 629–34.
26 Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. 
Segmented regression analysis of interrupted time series studies in 
medication use research. J Clin Pharm Ther 2002; 27: 299–309.
27 Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction 
to meta-analysis. Chichester: John Wiley & Sons, 2009.
28 Squires JE, Sullivan K, Eccles MP, Worswick J, Grimshaw JM. 
Are multifaceted interventions more effective than 
single-component interventions in changing health-care 
professionals’ behaviours? An overview of systematic reviews. 
Implement Sci 2014; 9: 152.
29 Forsetlund L, Bjørndal A, Rashidian A, et al. Continuing education 
meetings and workshops: effects on professional practice and 
health care outcomes. Cochrane Database Syst Rev 2009; 
2009: CD003030.
30 Giguère A, Légaré F, Grimshaw J, et al. Printed educational 
materials: effects on professional practice and healthcare outcomes. 
Cochrane Database Syst Rev 2012; 2012: CD004398.
31 Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on 
professional practice and healthcare outcomes. 
Cochrane Database Syst Rev 2012; 2012: CD000259.
32 Sorsdahl K, Ipser JC, Stein DJ. Interventions for educating 
traditional healers about STD and HIV medicine. 
Cochrane Database Syst Rev 2009; 2009: CD007190.
33 Greenland S. Can meta-analysis be salvaged? Am J Epidemiol 1994; 
140: 783–87.
34 Bailar JC. The promise and problems of meta-analysis. 
N Engl J Med 1997; 337: 559–61.
35 Leslie HH, Gage A, Nsona H, Hirschhorn LR, Kruk ME. 
Training and supervision did not meaningfully improve quality of 
care for pregnant women or sick children in sub-Saharan Africa. 
Health Aff 2016; 35: 1716–24.
